| 08-Dec-25 |
Buy |
Matthew Moulding |
32.30p | 209,086,400 |
£67,534,910.09 |
| 24-Nov-25 |
Transfer To |
Matthew Moulding |
44.00p | 181,818,176 |
£79,999,997.01 |
| 24-Nov-25 |
Transfer To |
Matthew Moulding |
44.00p | 181,818,176 |
£79,999,997.01 |
| 08-Dec-25 |
Buy |
Matthew Moulding |
32.30p | 209,086,400 |
£67,534,910.09 |
| Matthew Moulding |
390,904,588 |
£179,503,387 |
| Charles Allen |
2,942,000 |
£1,350,966 |
| Damian Sanders |
487,487 |
£223,854 |
| Susan Jane Farr |
145,243 |
£66,696 |
| Helen Jones |
134,084 |
£61,571 |
| Gillian Kent |
53,500 |
£24,567 |
| Dean Moore |
53,143 |
£24,403 |
| Frasers Group plc |
172,357,765 |
£79,146,686 |
| Sofina Capital S.A |
127,494,951 |
£58,545,682 |
| Matthew Moulding |
98,596,539 |
£45,275,531 |
| Balderton Capital IV, L.P |
96,947,470 |
£44,518,278 |
| Qatar Investment Authority |
95,148,959 |
£43,692,402 |
| Merian Global Investors |
86,972,130 |
£39,937,602 |
| SB Northstar LP |
80,621,797 |
£37,021,529 |
| Jupiter Fund Management plc |
62,034,208 |
£28,486,108 |
| T. Rowe Price |
60,908,595 |
£27,969,227 |
| 11:55 |
1 @ 45.92p |
| 11:52 |
2,180 @ 45.92p |
| 11:46 |
750 @ 45.94p |
| 11:47 |
3,232 @ 45.80p |
| 11:45 |
1,183 @ 45.68p |
| CEO |
Matthew Moulding |
| CFO |
Damian Sanders |
| Chair |
Charles Allen |
Top of Page
You are here:
research